Effects of angiotensin II blockade on the development of autoimmune thyroiditis in nonobese diabetic mice

被引:7
作者
Mori, Kouki [1 ]
Yoshida, Katsumi [2 ]
Tania, Jun-ichi [1 ]
Nakagawa, Yoshinori [1 ]
Hoshikawa, Saeko [1 ]
Ozaki, Hiroshi [1 ]
Ito, Sadayoshi [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Sch Hlth Sci, Dept Med Technol, Sendai, Miyagi 980, Japan
关键词
angiotensin II; Hashimoto's thyroiditis; autoimmunity; NOD mouse;
D O I
10.1016/j.clim.2007.08.018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
We evaluated the effects of angiotensin II (Ang II) blockers, losartan, an Ang II receptor blocker, and enalapril, an angiotensin converting enzyme inhibitor, on the development of autoimmune thyroiditis in nonobese diabetic (NOD) mice, an animal model of Hashimoto's thyroiditis (HT). Mice were assigned into three groups, untreated, losartan-treated (30 mg/kg/day), and enalapril-treated (10 mg/kg/day) groups. Thyroiditis was induced by iodide ingestion (experiment 1) or mouse thyroglobulin (Tg) immunization (experiment 2). Both procedures effectively induced thyroiditis. While iodide ingestion failed to induce anti-mouse Tg antibody (TgAb) production, Tg immunization resulted in a significant increase in serum TgAb levels. In both experiments, neither losartan nor enalapril interfered with the development of thyroiditis and TgAb production. These results suggest that Ang II may not be associated with the development of autoimmune thyroiditis in NOD mice. Thus, the Ang II blockade may not have therapeutic potential in HT (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 35 条
[1]
Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis [J].
Ajjan, RA ;
Watson, PF ;
McIntosh, RS ;
Weetman, AP .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (03) :523-528
[2]
THYROID AUTOIMMUNITY [J].
CHAMPION, BR ;
COOKE, A ;
RAYNER, DC .
CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (06) :770-778
[3]
Inhibition of TGFβ1 by Anti-TGFβ1 antibody or lisinopril reduces thyroid fibrosis in granulomatous experimental autoimmune thyroiditis [J].
Chen, KM ;
Wei, YZ ;
Sharp, GC ;
Braley-Mullen, H .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6530-6538
[4]
Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells [J].
Constantinescu, CS ;
Goodman, DBP ;
Ventura, ES .
IMMUNOLOGY LETTERS, 1998, 62 (01) :25-31
[5]
EFFECTS OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR CAPTOPRIL ON EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS [J].
CONSTANTINESCU, CS ;
VENTURA, E ;
HILLIARD, B ;
ROSTAMI, A .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1995, 17 (03) :471-491
[6]
The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis [J].
Dalbeth, N ;
Edwards, J ;
Fairchild, S ;
Callan, M ;
Hall, FC .
RHEUMATOLOGY, 2005, 44 (01) :24-31
[7]
Analysis of susceptibility of NOD mice to spontaneous and experimentally induced thyroiditis [J].
Damotte, D ;
Colomb, E ;
Cailleau, C ;
Brousse, N ;
Charreire, J ;
Carnaud, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (11) :2854-2862
[8]
An ACE inhibitor reduces Th2 cytokines and TGF-β1 and TGF-β2 isoforms in murine lupus nephritis [J].
De Albuquerque, DA ;
Saxena, V ;
Adams, DE ;
Boivin, GP ;
Brunner, HI ;
Witte, DP ;
Singh, RR .
KIDNEY INTERNATIONAL, 2004, 65 (03) :846-859
[9]
FUKAZAWA M, 1997, IMMUNOPHARMACOLOGY, V36, P49
[10]
Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone [J].
Fukuyama, K ;
Ichiki, T ;
Takeda, K ;
Tokunou, T ;
Iino, N ;
Masuda, S ;
Ishibashi, M ;
Egashira, K ;
Shimokawa, H ;
Hirano, K ;
Kanaide, H ;
Takeshita, A .
HYPERTENSION, 2003, 41 (03) :598-603